Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
November 27, 2014
Variomics screen identifies the re-entrant loop of the calcium-activated chloride channel ANO1 that facilitates channel activation
Anke Bill, M Oana Popa, Michiel T van Diepen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2014
To "grow" or "go": TMEM16A expression as a switch between tumor growth and metastasis in SCCHN
Daniel J Shiwarski, Chunbo Shao, Anke Bill, et al.
Molecular and Cellular Biology
|
January 26, 2011
MK-STYX, a catalytically inactive phosphatase regulating mitochondrially dependent apoptosis
Natalie M Niemi, Nathan J Lanning, Jeff A Klomp, et al.
Genes, Chromosomes & Cancer
|
February 9, 2017
TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2
Sucheta Kulkarni, Anke Bill, Neal R Godse, et al.
Plos One
|
June 3, 2014
High throughput mutagenesis for identification of residues regulating human prostacyclin (hIP) receptor expression and function
Anke Bill, Elizabeth M Rosethorne, Toby C Kent, et al.
Virology
|
November 26, 2009
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
L Alex Gaither, Jason Borawski, Leah J Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 23, 2013
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling
Adrian Britschgi, Anke Bill, Heike Brinkhaus, et al.
Journal of Virology
|
July 17, 2009
Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication
Jason Borawski, Philip Troke, Xiaoling Puyang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2019
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
Patricia Fernández-Nogueira, Mario Mancino, Gemma Fuster, et al.
Journal of Medicinal Chemistry
|
March 23, 2018
Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer
George S Tria, Tinya Abrams, Jason Baird, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
November 27, 2014
Variomics screen identifies the re-entrant loop of the calcium-activated chloride channel ANO1 that facilitates channel activation
Anke Bill, M Oana Popa, Michiel T van Diepen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2014
To "grow" or "go": TMEM16A expression as a switch between tumor growth and metastasis in SCCHN
Daniel J Shiwarski, Chunbo Shao, Anke Bill, et al.
Molecular and Cellular Biology
|
January 26, 2011
MK-STYX, a catalytically inactive phosphatase regulating mitochondrially dependent apoptosis
Natalie M Niemi, Nathan J Lanning, Jeff A Klomp, et al.
Genes, Chromosomes & Cancer
|
February 9, 2017
TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2
Sucheta Kulkarni, Anke Bill, Neal R Godse, et al.
Plos One
|
June 3, 2014
High throughput mutagenesis for identification of residues regulating human prostacyclin (hIP) receptor expression and function
Anke Bill, Elizabeth M Rosethorne, Toby C Kent, et al.
Virology
|
November 26, 2009
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
L Alex Gaither, Jason Borawski, Leah J Anderson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 23, 2013
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling
Adrian Britschgi, Anke Bill, Heike Brinkhaus, et al.
Journal of Virology
|
July 17, 2009
Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication
Jason Borawski, Philip Troke, Xiaoling Puyang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2019
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
Patricia Fernández-Nogueira, Mario Mancino, Gemma Fuster, et al.
Journal of Medicinal Chemistry
|
March 23, 2018
Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer
George S Tria, Tinya Abrams, Jason Baird, et al.
Page
of 3